Tag: COMM

Blue Horseshoe Stocks: Options Review

Adobe, Inc. ADBE – Update

After continued success with SPY calls early this week and persisting through to their expiration yesterday, we issued yet another fresh options idea in yesterday morning’s premarket report for the ADBE chain.

ADBE reported a strong Q2 earnings beat and was looking ripe in the premarket. We signaled our interest in tracking the ADBE Weekly $285-290 Calls and we were exceedingly pleased with the idea’s first day performance, which yielded chances at multi-bag gains.

$289 Calls – Range: 2.94-7.40 – Max Gain: 152%
$289.50 Calls – Range: 1.83-5.25 – Max Gain: 187%
$290 Calls – Range: 1.07-3.51 – Max Gain: 228%

With the markets gapping up hard today, we would expect to see new highs on each of these contract, in which case we will report the final possible gains in tomorrow’s newsletters.
_____

MORE FRESH IDEAS: 
SPDR S&P500 (ETF) SPY Weekly $294-296 Calls
Commercial Metals Co. CMC Weekly $16-17 Calls
Oracle Corp. ORCL Weekly $55-56 Calls

Extended Watchlist:
IAG, ZYME, KGC, COMM, MLNT, SVM, URL

Blue Horseshoe Stocks: Earnings-Related Options Ideas

OPTIONS REVIEW

We closed out the short week on Thursday with a pair of last minute options ideas, and both of those provided our readers and ourselves with the opportunity to take significant intraday profits.

United Rentals Inc. URI Weekly $134-136 Calls
$134 Calls – Range: 1.65-4.20  – Max Gain: 155%
$135 Calls – Range: .91-3.50 – Max Gain: 285%
$136 Calls – Range: .85-2.73  – Max Gain: 221%

Union Pacific Corp. UNP Weekly $172.50 & 175 Calls
$172.50 Calls – Range: 2.61-5.07  – Max Gain: 94%
$175 Calls – Range: .84-2.95 – Max Gain: 251%

______

EARNINGS RELATED OPTIONS IDEAS
Halliburton Co. HAL Weekly $31.50-32.50 Calls
Kimberly Clark Corp. KMB Weekly $125-128 Calls

Moleculin Biotech, Inc. MBRX – Recap

We highlighted this play at the end of last month, and shortly thereafter we would observe a low of .7772. Last week, MBRX reached a new high of 1.47, which translates to a gain of 89% in roughly three weeks’ time.

The move, which filled the entirety of the topside gap on the chart, was due to Thursday’s revelation that the company’s drug Annamycin had received the FDA’s Approval for fast-track designation. At 4:30PM on Wednesday, MBRX officials will conduct a call to discuss this and other developments on a live webcast, which will be available in the Investor Relations section at www.moleculin.com.

Extended Watchlist:
NBRV, TLGT, FCEL, UXIN, TENX, COMM, KEG, CEI,